Very Cheap Lice Drug Shows Promise With Improving COVID Patients Mortality Rates

Written by Wes Walker on January 5, 2021

Become a Clash Insider!

Big Tech is clamping down on conservative media big time. Don’t let Big Tech pre-chew your news. Sign up for our free email newsletter, and we’ll make sure to keep you in the loop.

Follow Doug on Parler @TheGilesWay.

How many lives were thrown away because our politicized response to the Chinavirus blinded us to simple, cheap, and effective treatments that had no grand patent potential?

The most glaring example was how the CDC quietly reversed its guidance on HCQ long after the election.

Early in the pandemic, Trump referenced a promising study — published in the LANCET, no less — suggesting a cheap drug with a decades-long track record of safety could keep some percentage of existing Coronavirus cases from hitting the critical mass of the cytokine storm which had caused such lethal havoc in the systems of so many patients.

Trump was declared anti-science, and that drug was demonized to the point that social media was censoring or deleting pages that suggested that people might have reason to consider it as, not a silver bullet, but perhaps a prophylactic measure to avert the worst effects.

Doctors who had seen documented success in their practices by the use of it were maligned in the public square as being quacks.

And yet, despite the collective wisdom of our betters in the media and big tech censoring us, they were not telling us the truth about HCQ. It was, at best, political spin and conjecture. STUDY: COVID Patients Treated With Hydroxychloroquine See 84% Fewer Hospitalizations

What else did we miss while the nation was being molded by fear that ripped the guts out of so much of the working-class economy? What other simple solutions did we ignore while desperately looking for that silver-bullet vaccine?

Solutions like this one that’s about $2 per every full course of treatment.

A drug used to treat head lice could cut the risk of death for hospitalised Covid patients by up to 80 per cent, a study suggests.

Ivermectin, a prescription-only drug that can cost as little as £1.50 for a course of treatment, was also found to potentially halve the time critically-ill patients needed care for.

Dr Andrew Hill, a virologist from Liverpool University behind the analysis, claimed the drug could be ‘transformational’ in the battle against the virus.

…Ivermectin was discovered in the 1970s and has fast become an essential medicine for a vast number of parasitic infections, such as head lice and scabies.

It is branded as Stromectol, an oral tablet for scabies and Soolantra, a skin cream for rosacea. It is branded as Sklice for treating head lice, which was approved in the US this year.

Today it is prescribed on the NHS and in the US for these conditions, but some scientists argue it could also be useful against Covid-19.

Scientists investigating the drug believe it works by paralysing the SARS-CoV-2 virus and ‘overwhelming its nervous system’, to prevent it from replicating. —DailyMail

Related…

MD Challenges Little Lord Fauci’s Critique Of Controversial Drug Trial

The Anti-Trump Media(D) Are Ignoring These 7 Stories Because They Might Help Trump In November